Specialty Drugs

The High Cost of Hemophilia – Part 2

Aug 1, 2019

Hemophilia is a rare blood clotting disorder that affects approximately 20,000 people in the United States and an estimated total of 400,000 people worldwide.  The symptoms can range from mild to severe; but keeping it under control often dictates a need for prophylactic or preventative treatment to ensure that bleeding does not become an issue. Bleeding issues often lead to additional medical care, including hospital stays, which means additional costs for employers and the insured. Due to its rarity, the treatments are often extremely expensive. Hemophilia not only an impact upon a person's quality of life, but can be quite the financial...

Read More

Filed Under: changes in healthcare, Corporate Benefits, hemophilia, high-cost drugs, medications, negotiate medical bills, Specialty Drugs

The High Cost of Hemophilia – Part 1

Jul 25, 2019

Hemophilia is a rare clotting disorder that causes blood to not clot properly. It causes more than normal bleeding when someone is injured and can be life threatening. This very rare and usually inherited disorder affects approximately 20,000 people in the United States. The  severity of the disease can vary dramatically between affected individuals and the severity, from mild to severe would dictate the level of medical care one needs. It can not only be financially costly, something we will discuss in part 2, but also physically costly; which is what is discussed in part one of this article series. The basics...

Read More

Filed Under: changes in healthcare, Corporate Benefits, high-cost drugs, medications, negotiate medical bills, Specialty Drugs

The Drug Waste Problem: Cancer & Specialty Drugs

Jul 12, 2019

The pharmaceutical side of oncology and other specialty drugs is a multi-billion dollar business. This is one of the highest cost segments of pharmaceuticals to patients and insurance companies, and it is one of the highest profit areas for the pharmaceutical companies. In 2016, specialty drugs made up 40% of the $450 billion pharmaceutical market, which translates into $180 billion. This staggering amount of money is bad enough in itself, but what if I told you that some of those medications that make up that $180 billion was being wasted in hospitals and other healthcare centers every single day? How Can...

Read More

Filed Under: cancer drugs cost, cancer treatments, elder care, Health Management, high-cost drugs, medications, overmedication, polypharmacy, Specialty Drugs, understanding insurance

The High Cost of Cancer Drugs

Jul 5, 2019

Cancer strikes fear in the heart of anyone, no matter what their age. How cancer treatments affect your body can be scary, but it can also have huge financial ramifications for you and your family as well. The treatments given to combat cancer have increased the life expectancy and outcomes for many patients, but this increase comes at a cost many find difficult to bear.  The Financial Cost of Treatment Cancer drugs are continually being released and the prices are continually going up. Between 2009 and 2014, the cancer drugs that were launched were priced at $100,000 or more per patient for...

Read More

Filed Under: cancer drugs cost, cancer treatments, high-cost drugs, insurance coverage, lower medical bills, medications, overmedication, Specialty Drugs